Press Releases

Date Title and Summary Additional Formats
Toggle Summary Fluidigm to Report Q2 2017 Financial Results and Host Conference Call
SOUTH SAN FRANCISCO, Calif. , July 20, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that it will report second quarter 2017 financial results on Thursday, August 3, 2017 , after the financial markets close. Chris Linthwaite , President and CEO, and Vikram Jog , Chief
View HTML
Toggle Summary Fluidigm Introduces Immuno-Oncology Gene Expression Assay for Translational and Clinical Research
Advanta Immuno-Oncology Gene Expression Assay enables efficient screening of 170 highly informative genes involved in human checkpoint therapeutic response
View HTML
Toggle Summary European Mass Cytometry Consortium Brings CyTOF Technology to Leading Universities to Advance Clinical Research
SOUTH SAN FRANCISCO, Calif. , May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that leading research institutions in the UK have partnered to acquire and implement seven Helios™ mass cytometry systems to empower life-changing discoveries in human health.
View HTML
Toggle Summary Fluidigm Announces First Quarter Financial Results
SOUTH SAN FRANCISCO, Calif. , May 04, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2017 .  Total revenue for the quarter was $25.5 million , a decrease of 12% from $29.0 million in the first quarter of 2016
View HTML
Toggle Summary Fluidigm To Report Q1 2017 Financial Results And Host Conference Call
SOUTH SAN FRANCISCO, Calif., April 20, 2017 — Fluidigm Corporation (NASDAQ:FLDM) today announced it will report first quarter 2017 financial results on Thursday, May 4, 2017, after the financial markets close.   Chris Linthwaite, President and CEO, and Vikram Jog, Chief Financial Officer, will host
View HTML
Toggle Summary Nicolas Barthelemy and Carlos Paya Join Fluidigm Board of Directors
SOUTH SAN FRANCISCO, Calif., March 27, 2017 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Nicolas Barthelemy and Dr. Carlos Paya have been appointed to its Board of Directors.   Barthelemy brings over 25 years of health care industry experience to the Fluidigm Board, having served in
View HTML
Toggle Summary Fluidigm to Present at Cowen and Company 37th Annual Health Care Conference
SOUTH SAN FRANCISCO, Calif., February 23, 2017 – Fluidigm Corporation (NASDAQ:FLDM) today announced that Chris Linthwaite, President and CEO, will present at the Cowen and Company 37th Annual Health Care Conference on Tuesday, March 7, 2017 at 9:20 am ET in Boston, Massachusetts.
View HTML
Toggle Summary Fluidigm Announces Q4 And Full Year 2016 Financial Results
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2017 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM ) today announced its financial results for the fourth quarter and full year ended December 31, 2016.  Total revenue for the fourth quarter of 2016 was $25.1 million, an increase of 13% from
View HTML
Toggle Summary Fluidigm to Report Q4 and Full Year 2016 Financial Results
SOUTH SAN FRANCISCO, Calif., January 25, 2017 — Fluidigm Corporation (NASDAQ:FLDM) today announced it will report fourth quarter and full year 2016 financial results on Wednesday, February 8, 2017, after the financial markets close. Chris Linthwaite, President and Chief Executive Officer, and
View HTML
Toggle Summary Fluidigm Announces Preliminary Revenue for the Fourth Quarter and Full Year
Ended December 31, 2016
View HTML